Search research articles
Contact Us
Filters
Showing results (101-110 of 162) with videos related to
Page
of 17
Sort By:
American Journal of Hematology
|
May 14, 2026
Timing and Pattern of Extraosseous Dissemination Are Key Determinants of Survival in Multiple Myeloma
Mickael Tordjman, Anis Meribout, Amine Geahchan, et al.
Cancer Cell
|
July 9, 2021
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Oliver Van Oekelen, Charles R Gleason, Sarita Agte, et al.
Blood Advances
|
January 29, 2024
Regression of smoldering myeloma with treatment of Gaucher disease
Kevin Barley, Anshuman Parekh, Syed Salam, et al.
Cell Reports. Medicine
|
May 22, 2024
Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma
Oliver Van Oekelen, Michael Amatangelo, Manman Guo, et al.
Science Advances
|
November 17, 2021
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2019
Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma
Deepak Perumal, Naoko Imai, Alessandro Laganà, et al.
JCO Precision Oncology
|
February 2, 2019
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
Alessandro Laganà, Itai Beno, David Melnekoff, et al.
Blood
|
May 12, 2026
Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathways
Hsiling Chiu, Junfei Zhao, Tara Basavanhally, et al.
Blood Advances
|
January 4, 2018
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
Ajai Chari, Hearn J Cho, Amishi Dhadwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma
Shashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 162) with videos related to
Sort By:
Page
of 17
American Journal of Hematology
|
May 14, 2026
Timing and Pattern of Extraosseous Dissemination Are Key Determinants of Survival in Multiple Myeloma
Mickael Tordjman, Anis Meribout, Amine Geahchan, et al.
Cancer Cell
|
July 9, 2021
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Oliver Van Oekelen, Charles R Gleason, Sarita Agte, et al.
Blood Advances
|
January 29, 2024
Regression of smoldering myeloma with treatment of Gaucher disease
Kevin Barley, Anshuman Parekh, Syed Salam, et al.
Cell Reports. Medicine
|
May 22, 2024
Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma
Oliver Van Oekelen, Michael Amatangelo, Manman Guo, et al.
Science Advances
|
November 17, 2021
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2019
Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma
Deepak Perumal, Naoko Imai, Alessandro Laganà, et al.
JCO Precision Oncology
|
February 2, 2019
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
Alessandro Laganà, Itai Beno, David Melnekoff, et al.
Blood
|
May 12, 2026
Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathways
Hsiling Chiu, Junfei Zhao, Tara Basavanhally, et al.
Blood Advances
|
January 4, 2018
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
Ajai Chari, Hearn J Cho, Amishi Dhadwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma
Shashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Page
of 17